Increased risk for irritable bowel syndrome after acute diverticulitis. - Wikidata - awgldk - TriplyDB

Increased risk for irritable bowel syndrome after acute diverticulitis.

Increased risk for irritable bowel syndrome after acute diverticulitis.

http://www.wikidata.org/entity/Q38092548

about

Diagnosis, Differential Diagnoses, and Classification of Diverticular Disease Recent advances in the treatment of colonic diverticular disease and prevention of acute diverticulitis Logical hypothesis: Low FODMAP diet to prevent diverticulitis Recent Advances in Diverticular Disease.Updates in diverticular disease.Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.Association between the location of diverticular disease and the irritable bowel syndrome: a multicenter study in Japan Changing views on diverticular disease: impact of aging, obesity, diet, and microbiota.The genetic epidemiology of diverticulosis and diverticular disease: Emerging evidence Temporal Trends in the Incidence and Natural History of Diverticulitis: A Population-Based Study Distribution and Characteristics of Colonic Diverticula in a United States Screening Population.Colonic Diverticula and Diverticular Disease: 10 Facts Clinicians Should Know Association Between Colonic Diverticulosis and Erectile Dysfunction: A Nationwide Population-Based Study.Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL.Diverticular disease: changing epidemiology and management.Clinically Diagnosed Acute Diverticulitis in Outpatients: Misdiagnosis in Patients with Irritable Bowel Syndrome.Incidence and predictive factors of irritable bowel syndrome after acute diverticulitis in Korea.Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy.Diverticular disease of the colon and irritable bowel syndrome: it is time to differentiate.A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease.Abundance of Enterobacteriaceae in the colon mucosa in diverticular disease.High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment.Progress and challenges in the management of diverticular disease: which treatment?

P2860

Q26753875-BC06BBF1-C506-4644-83E0-3D116B027CCD Q26769903-23A31D2D-C591-4B1C-85F4-15547E639637 Q28075703-23AAA80B-056C-4B50-97CF-F18DF371E041 Q30250041-DC5152EF-5B3E-4BE7-9C19-C7851FF17CC7 Q34369046-6F233FE9-083F-43C7-BFCB-C4C01FA08410 Q34486456-DED3E156-835C-481F-BF6B-E6266FB05BFC Q34664668-19FE6E40-9D9D-4037-9CBA-55D9BE062FD2 Q35565092-C15D5313-1B2D-4D45-8EE2-51F558B3E92B Q36223534-23F6B0FA-AB32-4354-AFBF-0F2D61D52074 Q36365804-97DCFC20-8A7C-45EE-8868-07F0C88367BD Q37018539-1FFC3E09-62F3-4801-8487-1C2EA8258CD4 Q37197547-7A4F3A03-CDCF-4AA0-BAE8-FBAAF72F1465 Q37328552-2ED34C1B-475F-4E64-8666-64F8D83CFB60 Q38233600-D3F92040-1233-4882-BDB9-FB53D128FDFC Q38429707-B15E391A-F63C-45A0-B2E5-900BFA906E19 Q40964197-7548BB0E-FAF6-4986-92E3-4DAA6102A00B Q41726271-76E82C25-450C-4BA9-B6CC-621AA8EEC55E Q46164462-F59E3413-01A1-44AE-8495-8E17F040876E Q53517126-5737581E-A271-4747-A5C1-248E79D5CDD3 Q54087826-9B8A9F2C-4372-4C98-9CDD-8869FBD83325 Q54967207-A3076992-1905-43CE-85D6-132A11C89645 Q55438022-C8F62B53-1BD9-4380-8DA5-13A289AD6380 Q57652297-AB7BABB5-8DD6-40E8-B77C-A01C75756310

P2860

Increased risk for irritable bowel syndrome after acute diverticulitis.

http://www.wikidata.org/entity/Q38092548

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Increased risk for irritable bowel syndrome after acute diverticulitis.

@en

type

label

Increased risk for irritable bowel syndrome after acute diverticulitis.

@en

prefLabel

Increased risk for irritable bowel syndrome after acute diverticulitis.

@en

P1433

Q38092548-A4EA7487-D79F-41AA-82FD-49D86CC6E0FB

P1476

Q38092548-497D56FD-EC94-4119-AB5B-E458A0944B6A

P2093

Q38092548-098579E3-D014-457C-B1CB-C0B4BB8F6513

Q38092548-09A9FF36-D3B6-4207-90F6-997FC3A17364

Q38092548-0E683C5B-7077-4173-8708-D78C54BF37B5

Q38092548-2B9C2153-041B-4AEC-9CC4-763BE1C548CA

Q38092548-30BDEE76-780E-4DFF-A905-67E25DD2A84C

Q38092548-465967D3-F5DB-4826-AC29-F62BF59E135C

Q38092548-4F1E6CB9-89A5-4F32-A07D-C16DE1306DE8

Q38092548-6CD13442-5125-4E19-A6B0-F38FE24E5397

Q38092548-798A8E7E-D172-422D-B7E0-7A2B92AFF08B

Q38092548-7B8CCBD6-184B-4E60-9BEB-6AA6AFDA80FB

P2860

Q38092548-2AD521CA-B4EE-4BDF-86E4-6CFF58A7FFEC

Q38092548-37523756-AFB4-45FE-B0D4-5A9A4110B84C

Q38092548-56FCC902-CB37-4237-8B63-01CB78E25EDA

Q38092548-574CF3BF-1594-4236-AC0C-786055DCB129

Q38092548-5CA54FE5-1F31-444A-892B-3F6BBE96D66E

Q38092548-5E08BEB1-D610-4BD8-BEAC-C3527165C6B9

Q38092548-7363E1ED-4875-4E7C-96B0-47B3D6EB01D4

Q38092548-73DF05AD-DF5E-4C9A-876C-3F85996CDE4B

Q38092548-81B86F86-92EA-4484-83CF-7521D1D73684

Q38092548-843A657D-3D5D-47F8-9C7E-8ADBAC2F8654

P304

Q38092548-BD585B36-3FE8-4BC3-8827-C65BA44FF8E9

P31

Q38092548-B9852903-780F-4719-9669-2F0FED96C45F

P356

Q38092548-ACB36350-1321-4A8D-B704-4DA68361E5C8

P407

Q38092548-1FAFB953-1396-4440-856B-9654C2B6270F

P433

Q38092548-C746F8F3-138C-4586-88D9-E041CA0032A1

P478

Q38092548-4C128984-08A6-4FD6-8840-269A0BEE8A89

P577

Q38092548-833E8124-5E2A-422E-80E4-DA05FEAEF65B

P698

Q38092548-2AEFD855-49B8-4A27-8894-B531105426E4

P932

Q38092548-0F86ED85-DA96-40D9-BC9D-145D5301E6B2

P356

J.CGH.2013.03.007

P1433

Clinical Gastroenterology and Hepatology

P1476

Increased risk for irritable bowel syndrome after acute diverticulitis.

@en

P2093

Brennan Spiegel

http://www.w3.org/2001/XMLSchema#string

Erica Cohen

http://www.w3.org/2001/XMLSchema#string

Garth Fuller

http://www.w3.org/2001/XMLSchema#string

Kamyar Shahedi

http://www.w3.org/2001/XMLSchema#string

Linnette Yen

http://www.w3.org/2001/XMLSchema#string

M Haim Erder

http://www.w3.org/2001/XMLSchema#string

Marc Kaneshiro

http://www.w3.org/2001/XMLSchema#string

Mary Atia

http://www.w3.org/2001/XMLSchema#string

Michelle Vu

http://www.w3.org/2001/XMLSchema#string

Nicole Kurzbard

http://www.w3.org/2001/XMLSchema#string

P2860

Rifaximin therapy for patients with irritable bowel syndrome without constipation

Functional bowel disorders

National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data.

Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study.

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome.

Atypical diverticular disease: surgical results.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.

Evolving pathophysiologic models of functional gastrointestinal disorders.

P304

1614-1619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2013.03.007

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23524129

http://www.w3.org/2001/XMLSchema#string

P932

5731449

http://www.w3.org/2001/XMLSchema#string